BioWorld MedTech

Jan. 28, 2013

InTouch gains clearance for RP-VITA for use in hospitals

A partnership between two companies has led to the development of an autonomous robotic system, which could have the potential to significantly make the jobs of physicians and clinicians a bit easier. Read More

Cytox raises $5.5M to continue Alzheimer's test development

International report: Varian selected to equip cancer center in Algeria

Washington roundup: Device contractors in limbo in new combo product final rule

Financings roundup: LipoScience reports pricing of initial public offering

Grants roundup: Arsenal Medical will provide injectable foam to military

Court report: HCA must pay $162M to Kansas City area community foundation

Agreements/contracts: Tenet's San Ramon Regional joins with John Muir Health

Med-Tech Notes

People in the News

Product Briefs

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for Dec. 12, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 12, 2025.

CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

BioWorld

A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...

Illustration of head with maze that is missing parts

CTAD 2025: The challenges of combination therapies for dementia

BioWorld Science

At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...

DEE-lightful: Praxis’ phase II results allow stock to flex its muscle

BioWorld

Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...